Stratophase Announces a Joint Collaboration With Merck

Romsey, United Kingdom --- Stratophase, a biotech services and technology company, has entered into a joint collaboration agreement with Merck science and technology company. The collaboration will see the application of Stratophase’s Ranger technology to Merck’s cell culture manufacturing platforms and the development of dynamic control strategies that enable complex feeding regimes to be optimised and controlled in real-time. Enhancement of the existing Ranger system’s capabilities to enable control of cell culture processes with complex feeding requirements is aligned with the biopharmaceutical industry’s increasing need for high performance and robust processes that can be optimised and implemented within minimum timelines.

Suggested Articles

U.S. Commerce Department beefs up attacks on TikTok and WeChat, banning downloads at first. Eventually the bans will be total, unless some other agree

Analyst Jack Gold describes the TikTok battle as a big win for China.

Analyst Leonard Lee argues that if Nvidia can get regulatory approvals to buy Arm, the entity would be a challenge to Intel's data center dominance.…